Cargando…
Comparison of two ovarian stimulation protocols among women with poor response: A randomized clinical trial
This is a randomized controlled trial conducted in a tertiary referral fertility department. Participants were women with previous poor ovarian response undergoing in vitro fertilization. (IVF). One hundred and ninety-two women were randomized to the short GnRH agonist and antagonist regimens. The p...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580530/ https://www.ncbi.nlm.nih.gov/pubmed/35796739 http://dx.doi.org/10.4081/ejtm.2022.10634 |
_version_ | 1784812407633215488 |
---|---|
author | Bavarsadkarimi, Minoodokht Omidi, Sirous Shahmoradi, Farinaz Heidar, Zahra Mirzaei, Sahar |
author_facet | Bavarsadkarimi, Minoodokht Omidi, Sirous Shahmoradi, Farinaz Heidar, Zahra Mirzaei, Sahar |
author_sort | Bavarsadkarimi, Minoodokht |
collection | PubMed |
description | This is a randomized controlled trial conducted in a tertiary referral fertility department. Participants were women with previous poor ovarian response undergoing in vitro fertilization. (IVF). One hundred and ninety-two women were randomized to the short GnRH agonist and antagonist regimens. The primary outcome was the number of oocytes retrieved. Secondary outcome measures were the number of embryos transferred, chemical and clinical pregnancy rate and live birth. The number of oocytes retrieved was higher with the gonadotrophin-releasing hormone (GnRH) antagonist regimen compared to the short agonist regimen (3.10 2.70 vs. 2.992.60), but there was no significant difference. The duration of stimulation and total gonadotropin dose were higher with short agonist regimens compared to antagonist regimens, with the latter being statistically significant (p < 0.001). The chemical pregnancy rate was 8.33 percent with the short agonist regimen and 7.29 percent with the antagonist regimen, with no statistically significant difference (p = 0.79). In terms of lower cycles cancelation and higher chemical pregnancy, short GnRH agonist regim is appropriate choice for poor responders. |
format | Online Article Text |
id | pubmed-9580530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | PAGEPress Publications, Pavia, Italy |
record_format | MEDLINE/PubMed |
spelling | pubmed-95805302022-10-20 Comparison of two ovarian stimulation protocols among women with poor response: A randomized clinical trial Bavarsadkarimi, Minoodokht Omidi, Sirous Shahmoradi, Farinaz Heidar, Zahra Mirzaei, Sahar Eur J Transl Myol Article This is a randomized controlled trial conducted in a tertiary referral fertility department. Participants were women with previous poor ovarian response undergoing in vitro fertilization. (IVF). One hundred and ninety-two women were randomized to the short GnRH agonist and antagonist regimens. The primary outcome was the number of oocytes retrieved. Secondary outcome measures were the number of embryos transferred, chemical and clinical pregnancy rate and live birth. The number of oocytes retrieved was higher with the gonadotrophin-releasing hormone (GnRH) antagonist regimen compared to the short agonist regimen (3.10 2.70 vs. 2.992.60), but there was no significant difference. The duration of stimulation and total gonadotropin dose were higher with short agonist regimens compared to antagonist regimens, with the latter being statistically significant (p < 0.001). The chemical pregnancy rate was 8.33 percent with the short agonist regimen and 7.29 percent with the antagonist regimen, with no statistically significant difference (p = 0.79). In terms of lower cycles cancelation and higher chemical pregnancy, short GnRH agonist regim is appropriate choice for poor responders. PAGEPress Publications, Pavia, Italy 2022-07-06 /pmc/articles/PMC9580530/ /pubmed/35796739 http://dx.doi.org/10.4081/ejtm.2022.10634 Text en https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Bavarsadkarimi, Minoodokht Omidi, Sirous Shahmoradi, Farinaz Heidar, Zahra Mirzaei, Sahar Comparison of two ovarian stimulation protocols among women with poor response: A randomized clinical trial |
title | Comparison of two ovarian stimulation protocols among women with poor response: A randomized clinical trial |
title_full | Comparison of two ovarian stimulation protocols among women with poor response: A randomized clinical trial |
title_fullStr | Comparison of two ovarian stimulation protocols among women with poor response: A randomized clinical trial |
title_full_unstemmed | Comparison of two ovarian stimulation protocols among women with poor response: A randomized clinical trial |
title_short | Comparison of two ovarian stimulation protocols among women with poor response: A randomized clinical trial |
title_sort | comparison of two ovarian stimulation protocols among women with poor response: a randomized clinical trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580530/ https://www.ncbi.nlm.nih.gov/pubmed/35796739 http://dx.doi.org/10.4081/ejtm.2022.10634 |
work_keys_str_mv | AT bavarsadkarimiminoodokht comparisonoftwoovarianstimulationprotocolsamongwomenwithpoorresponsearandomizedclinicaltrial AT omidisirous comparisonoftwoovarianstimulationprotocolsamongwomenwithpoorresponsearandomizedclinicaltrial AT shahmoradifarinaz comparisonoftwoovarianstimulationprotocolsamongwomenwithpoorresponsearandomizedclinicaltrial AT heidarzahra comparisonoftwoovarianstimulationprotocolsamongwomenwithpoorresponsearandomizedclinicaltrial AT mirzaeisahar comparisonoftwoovarianstimulationprotocolsamongwomenwithpoorresponsearandomizedclinicaltrial |